Literature DB >> 15569284

Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease.

A S Day1, K E Whitten, T D Bohane.   

Abstract

OBJECTIVES: The use of complementary and alternative medicines (CAM) appears increasingly prevalent in children and adolescents. Individuals with chronic illness may have patterns of greater usage. This questionnaire-based study aimed to ascertain the frequency of use by a group of children with proven inflammatory bowel disease (IBD) and to consider the reasons for their use.
METHODS: A questionnaire was sent by mail to the parents of patients currently attending a paediatric IBD clinic. Parents were asked to describe their child's usage of alternative and probiotic therapies and to comment on a number of aspects of such therapies.
RESULTS: Forty-six (77%) of 60 mailed questionnaires were returned. The mean age of the children was 10.9 (+/- 4.1) years and they were taking an average of 1.7 (+/- 0.8) prescribed medications. Thirty-three (72%) of the children were said by their parents to be having CAM, with four having five or more such therapies (average 2.4 +/- 1.3 agents per child). The most commonly used agents were probiotics (78%) and fish oils (56%). A minority (12%) of respondents reported that their child's CAM was very effective, although many (50%) noted partial benefits. The 13 children who had never used any CAM therapies ('non-users') did not differ from the 'users' in terms of gender, age, disease or duration of disease. As expected, non-users expressed greater concerns about use of CAM and described different attitudes towards such therapies.
CONCLUSION: Complementary and alternative medicines, especially probiotic therapies, frequently are administered to children and adolescents with inflammatory bowel disease. Often this appears to be due to parental frustration with managing their child's chronic illness. Practitioners caring for children and adolescents with IBD need to be aware that their patients may be using alternative therapies and adopt an open attitude in this situation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15569284     DOI: 10.1111/j.1440-1754.2004.00510.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  16 in total

1.  Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study.

Authors:  David L Suskind; Ghassan Wahbeh; Tyler Burpee; Morty Cohen; Dennis Christie; Wendy Weber
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-03       Impact factor: 2.839

2.  Response to strict and liberalized specific carbohydrate diet in pediatric Crohn's disease.

Authors:  Jennifer C Burgis; Kaylie Nguyen; K T Park; Kenneth Cox
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

3.  Complementary and alternative medicine use and quality of life in pediatric diabetes.

Authors:  Rachelle L McCarty; Wendy J Weber; Beth Loots; Cora Collette Breuner; Ann Vander Stoep; Lisa Manhart; Catherine Pihoker
Journal:  J Altern Complement Med       Date:  2010-02       Impact factor: 2.579

4.  Use of complementary medicine in pediatric patients with inflammatory bowel disease: results from a multicenter survey.

Authors:  Anthony P Wong; Ann L Clark; Elizabeth A Garnett; Michael Acree; Stanley A Cohen; George D Ferry; Melvin B Heyman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2009-01       Impact factor: 2.839

5.  Predictors of medication adherence in pediatric inflammatory bowel disease patients at the Stollery Children's Hospital.

Authors:  L Kitney; J M Turner; D Spady; B Malik; W El-Matary; R Persad; H Q Huynh
Journal:  Can J Gastroenterol       Date:  2009-12       Impact factor: 3.522

6.  Mind-body complementary alternative medicine use and quality of life in adolescents with inflammatory bowel disease.

Authors:  Sian Cotton; Yvonne Humenay Roberts; Joel Tsevat; Maria T Britto; Paul Succop; Meghan E McGrady; Michael S Yi
Journal:  Inflamm Bowel Dis       Date:  2010-03       Impact factor: 5.325

Review 7.  On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies.

Authors:  Roja Rahimi; Shilan Mozaffari; Mohammad Abdollahi
Journal:  Dig Dis Sci       Date:  2008-07-10       Impact factor: 3.199

8.  Validation of a Revised Knowledge Assessment Tool for Children with Inflammatory Bowel Disease (IBD-KID2).

Authors:  Angharad Vernon-Roberts; Anthony Otley; Chris Frampton; Richard B Gearry; Andrew S Day
Journal:  Inflamm Intest Dis       Date:  2020-02-21

Review 9.  Probiotics in inflammatory bowel diseases and associated conditions.

Authors:  David R Mack
Journal:  Nutrients       Date:  2011-02-17       Impact factor: 5.717

10.  A cross-sectional survey of complementary and alternative medicine use by children and adolescents attending the University Hospital of Wales.

Authors:  Nigel W Crawford; Domenic R Cincotta; Alissa Lim; Colin V E Powell
Journal:  BMC Complement Altern Med       Date:  2006-05-02       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.